Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1992-07-13
1995-03-28
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
514 53, 514 57, 514 59, 514557, A61K 4900, A61K 31715, A61K 3119
Patent
active
054014913
ABSTRACT:
An agent for modifying H.sub.2 O relaxation times in NMR diagnosis comprises a polysaccharide having chemically linked to it an organic complexant to which is complexed a paramagnetic metal ion. Polysaccharides include cellulose, starch, sepharose and dextran. Organic complexants include EDTA, DTPA and aminoethyl diphosphonate. A preferred metal ion is Gadolinium (III). The agents can be administered orally or parenterally.
REFERENCES:
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4423158 (1983-01-01), Porath
patent: 4615879 (1986-10-01), Runge et al.
patent: 4647447 (1987-03-01), Gries et al.
patent: 4719098 (1988-01-01), Weinmann et al.
Harding Charles T.
Sadler John P.
Guerbet S.A.
Henley III Raymond
Weddington K.
LandOfFree
NMR contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMR contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMR contrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2248750